| 2026 |
| 11/13 | 5,152 | 5,216 | 5,093 | 5,186 | +0.31% | 1,572,900 | - | +4.28% |
| 11/13 | (IR情報)8:30 「レケンビ」の皮下注製剤「レケンビ皮下注250mgペン」日本において早期アルツハイマー病治療剤として新発売 |
| 11/12 | 5,048 | 5,170 | 5,027 | 5,170 | +2.89% | 1,456,300 | - | +4.42% |
| 11/11 | 4,910 | 5,087 | 4,910 | 5,025 | +0.3% | 1,659,000 | - | +1.91% |
| 11/10 | (IR情報)15:30 2027年3月期第2四半期(中間期)決算短信〔IFRS〕(連結) |
| 11/10 | (IR情報)15:30 2026年度(2027年3月期)第2四半期(中間期)決算参考資料 |
| 11/10 | (IR情報)15:30 2026年度第2四半期(中間期)決算説明会 |
| 11/10 | 5,130 | 5,138 | 5,010 | 5,010 | -0.58% | 1,187,300 | - | +1.89% |
| 11/09 | 4,986 | 5,072 | 4,966 | 5,039 | +3.73% | 1,571,100 | - | +2.75% |
| 11/06 | 5,191 | 5,220 | 4,818 | 4,858 | -7.99% | 2,016,500 | - | -0.78% |
| 11/05 | 5,123 | 5,284 | 5,123 | 5,280 | +6.09% | 2,158,000 | - | +7.84% |
| 11/04 | 4,947 | 5,006 | 4,938 | 4,977 | -0.78% | 1,136,100 | - | +2.05% |
| 11/02 | 5,072 | 5,109 | 4,990 | 5,016 | -0.71% | 930,300 | - | +2.89% |
| 10/30 | 5,014 | 5,103 | 5,002 | 5,052 | +1.57% | 1,344,000 | - | +3.69% |
| 10/29 | 4,972 | 5,065 | 4,920 | 4,974 | -1.87% | 2,177,500 | - | +2.22% |
| 10/28 | (IR情報)19:00 抗アミロイドβ抗体「レケンビ」の売上収益(速報)について |
| 10/28 | 5,130 | 5,168 | 5,063 | 5,069 | -0.65% | 1,070,500 | - | +4.19% |
| 10/27 | 5,033 | 5,116 | 5,005 | 5,102 | +0.08% | 1,134,000 | - | +4.98% |
| 10/26 | 5,100 | 5,131 | 5,052 | 5,098 | +0.43% | 983,800 | - | +5.18% |
| 10/23 | 5,100 | 5,192 | 5,057 | 5,076 | +0.42% | 1,669,900 | - | +5.01% |
| 10/22 | 5,005 | 5,083 | 4,962 | 5,055 | +0.16% | 1,470,900 | - | +4.85% |
| 10/22 | (空売り報告)Barclays Capital Securities Ltd 1,408,509株(0.48%)-0.05%義務消失 |
| 10/21 | 5,048 | 5,077 | 4,999 | 5,047 | +1.3% | 1,443,300 | - | +5.04% |
| 10/20 | 4,915 | 4,982 | 4,905 | 4,982 | +0.91% | 1,063,100 | - | +4.01% |
| 10/19 | 4,988 | 5,003 | 4,900 | 4,937 | +0.35% | 1,114,200 | - | +3.39% |
| 10/16 | 4,900 | 4,955 | 4,867 | 4,920 | +1.07% | 1,242,900 | - | +3.27% |
| 10/15 | 4,762 | 4,868 | 4,753 | 4,868 | +3.75% | 2,126,800 | - | +2.44% |
| 10/14 | 4,599 | 4,710 | 4,594 | 4,692 | +0.79% | 1,318,100 | - | -1.12% |
| 10/13 | 4,670 | 4,677 | 4,599 | 4,655 | +1.13% | 1,242,700 | - | -2% |
| 10/13 | (空売り報告)Barclays Capital Securities Ltd 1,564,751株(0.53%)再IN |
| 10/09 | 4,672 | 4,672 | 4,603 | 4,603 | -0.6% | 1,351,900 | - | -3.16% |
| 10/09 | (空売り報告)Barclays Capital Securities Ltd 1,076,751株(0.36%)-0.15%義務消失 |
| 10/09 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 1,428,218株(0.48%)-0.08%義務消失 |
| 10/08 | 4,710 | 4,728 | 4,571 | 4,631 | -0.19% | 1,059,400 | - | -2.69% |
| 10/08 | (空売り報告)Barclays Capital Securities Ltd 1,490,351株(0.51%)再IN |
| 10/07 | 4,677 | 4,714 | 4,640 | 4,640 | -0.77% | 960,300 | - | -2.6% |
| 10/06 | 4,679 | 4,695 | 4,645 | 4,676 | +0.36% | 1,052,800 | - | -1.99% |
| 10/05 | 4,705 | 4,739 | 4,659 | 4,659 | -0.87% | 935,900 | - | -2.47% |
| 10/02 | (IR情報)15:30 連結子会社からの配当金受領に関するお知らせ |
| 10/02 | 4,763 | 4,790 | 4,700 | 4,700 | -2.75% | 1,177,400 | - | -1.76% |
| 10/01 | 4,833 | 4,866 | 4,752 | 4,833 | -0.45% | 1,040,900 | - | +0.9% |
| 10/01 | (空売り報告)BNP Paribas Financial Markets SNC 1,385,853株(0.47%)-0.04%義務消失 |
| 09/30 | 4,820 | 4,866 | 4,735 | 4,855 | +0.91% | 1,494,600 | - | +1.36% |
| 09/30 | (空売り報告)BNP Paribas Financial Markets SNC 1,498,653株(0.51%)-0.28% |
| 09/29 | 4,851 | 4,859 | 4,774 | 4,811 | -2.24% | 1,241,300 | - | +0.4% |
| 09/28 | 4,944 | 4,982 | 4,914 | 4,921 | -0.69% | 1,267,900 | - | +2.56% |
| 09/25 | 4,958 | 5,003 | 4,921 | 4,955 | +1.08% | 1,189,600 | - | +3.34% |
| 09/25 | (空売り報告)Barclays Capital Securities Ltd 1,435,524株(0.49%)-0.07%義務消失 |
| 09/24 | 4,995 | 4,995 | 4,861 | 4,902 | -0.57% | 1,198,900 | - | +2.38% |
| 09/18 | 4,990 | 4,990 | 4,903 | 4,930 | -0.46% | 2,095,500 | - | +3.12% |
| 09/17 | 4,884 | 4,956 | 4,830 | 4,953 | +3.51% | 1,520,400 | - | +3.66% |
| 09/16 | (IR情報)15:00 早期アルツハイマー病治療剤「レケンビ」の皮下注製剤「レケンビ皮下注250 mgペン」、日本において承認取得 |
| 09/16 | 4,789 | 4,805 | 4,752 | 4,785 | +0.38% | 868,200 | - | +0.21% |
| 09/16 | (空売り報告)BNP Paribas Financial Markets SNC 2,317,184株(0.79%)-0.1% |
| 09/15 | 4,798 | 4,817 | 4,745 | 4,767 | +0.51% | 864,600 | - | -0.33% |
| 09/15 | (空売り報告)BNP Paribas Financial Markets SNC 2,603,414株(0.89%)+0.23% |
| 09/14 | 4,690 | 4,755 | 4,671 | 4,743 | +1.82% | 1,043,700 | - | -0.98% |
| 09/14 | (空売り報告)BNP Paribas Financial Markets SNC 1,936,514株(0.66%)+0.15% |
| 09/11 | 4,622 | 4,683 | 4,610 | 4,658 | -0.21% | 1,376,000 | - | -2.8% |
| 09/11 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 1,640,110株(0.56%)-0.06% |
| 09/10 | 4,599 | 4,668 | 4,592 | 4,668 | +1.04% | 1,345,400 | - | -2.61% |
| 09/10 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 1,817,310株(0.62%)+0.05% |
| 09/09 | 4,608 | 4,635 | 4,584 | 4,620 | -0.69% | 1,313,000 | - | -3.49% |
| 09/08 | 4,610 | 4,661 | 4,593 | 4,652 | +0.41% | 866,300 | - | -2.82% |
| 09/07 | 4,669 | 4,687 | 4,608 | 4,633 | -1.3% | 843,600 | - | -3.22% |
| 09/04 | 4,795 | 4,805 | 4,686 | 4,694 | -2.43% | 1,312,400 | - | -2.11% |
| 09/04 | (空売り報告)Barclays Capital Securities Ltd 1,634,659株(0.56%)再IN |
| 09/03 | (IR情報)13:00 「レケンビ」の皮下注射製剤、早期アルツハイマー病に対する初期療法として中国で承認取得 |
| 09/03 | 4,760 | 4,815 | 4,720 | 4,811 | +1.67% | 1,141,500 | - | +0.04% |
| 09/03 | (空売り報告)BNP Paribas Financial Markets SNC 1,489,247株(0.51%)再IN |
| 09/02 | 4,710 | 4,775 | 4,695 | 4,732 | -0.5% | 1,141,800 | - | -1.85% |
| 09/01 | 4,760 | 4,817 | 4,736 | 4,756 | +0.34% | 1,088,900 | - | -1.39% |
| 09/01 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 1,675,723株(0.57%)再IN |
| 08/31 | 4,754 | 4,795 | 4,721 | 4,740 | -1.74% | 2,105,200 | - | -1.72% |
| 08/31 | (空売り報告)Barclays Capital Securities Ltd 1,405,016株(0.48%)-0.06%義務消失 |
| 08/28 | 4,800 | 4,848 | 4,792 | 4,824 | +0.08% | 907,000 | - | +0.08% |
| 08/27 | 4,827 | 4,847 | 4,771 | 4,820 | -0.27% | 991,100 | - | +0.21% |
| 08/26 | 4,902 | 4,939 | 4,833 | 4,833 | -0.58% | 790,600 | - | +0.71% |
| 08/25 | 4,875 | 4,889 | 4,814 | 4,861 | +0.48% | 728,100 | - | +1.59% |
| 08/24 | 4,935 | 4,954 | 4,838 | 4,838 | -1.31% | 810,000 | - | +1.45% |
| 08/21 | 4,929 | 4,971 | 4,875 | 4,902 | -1.21% | 948,200 | - | +3.22% |
| 08/21 | (空売り報告)Barclays Capital Securities Ltd 1,600,646株(0.54%)-0.06% |
| 08/20 | 4,950 | 5,040 | 4,950 | 4,962 | +2.58% | 1,661,500 | - | +5.06% |
| 08/20 | (空売り報告)Barclays Capital Securities Ltd 1,754,781株(0.6%)+0.04% |
| 08/19 | 4,849 | 4,875 | 4,780 | 4,837 | +1.21% | 1,126,700 | - | +2.94% |
| 08/18 | 4,704 | 4,825 | 4,686 | 4,779 | +1.06% | 805,200 | - | +2.2% |
| 08/17 | 4,879 | 4,879 | 4,729 | 4,729 | -2.66% | 986,600 | - | +1.57% |
| 08/17 | (空売り報告)Barclays Capital Securities Ltd 1,653,281株(0.56%)-0.1% |
| 08/14 | 4,862 | 4,902 | 4,852 | 4,858 | -0.29% | 1,122,900 | - | +4.72% |
| 08/13 | 4,988 | 4,995 | 4,856 | 4,872 | -2.33% | 1,148,100 | - | +5.52% |
| 08/13 | (空売り報告)Barclays Capital Securities Ltd 1,931,481株(0.66%)-0.04% |
| 08/12 | 4,989 | 4,992 | 4,902 | 4,988 | +0.79% | 1,438,800 | - | +8.58% |
| 08/12 | (空売り報告)Barclays Capital Securities Ltd 2,053,881株(0.7%)+0.03% |
| 08/10 | 4,819 | 4,949 | 4,767 | 4,949 | +3.58% | 1,689,800 | - | +8.34% |
| 08/07 | 4,719 | 4,826 | 4,699 | 4,778 | +1.85% | 1,213,900 | - | +5.22% |
| 08/06 | 4,501 | 4,698 | 4,479 | 4,691 | +3.78% | 1,421,600 | - | +3.85% |
| 08/05 | 4,590 | 4,607 | 4,476 | 4,520 | -2.23% | 1,748,500 | - | +0.58% |
| 08/05 | (空売り報告)Barclays Capital Securities Ltd 1,958,681株(0.67%)-0.03% |
| 08/04 | 4,600 | 4,701 | 4,566 | 4,623 | -0.71% | 1,806,700 | - | +3.24% |
| 08/04 | (空売り報告)Barclays Capital Securities Ltd 2,045,181株(0.7%)+0.05% |
| 08/03 | (IR情報)15:30 2027年3月期第1四半期決算短信〔IFRS〕(連結) |
| 08/03 | (IR情報)15:30 2026年度(2027年3月期)第1四半期決算参考資料 |
| 08/03 | (IR情報)15:30 2026年度第1四半期決算説明会 |
| 08/03 | 4,807 | 4,816 | 4,538 | 4,656 | -3.56% | 2,274,700 | - | +4.42% |
| 08/03 | (空売り報告)Barclays Capital Securities Ltd 1,924,648株(0.65%)-0.06% |
| 07/31 | 4,900 | 4,947 | 4,805 | 4,828 | -4.03% | 2,497,600 | - | +8.94% |
| 07/30 | 5,057 | 5,132 | 4,897 | 5,031 | -1.55% | 2,428,300 | - | +14.42% |
| 07/30 | (空売り報告)Barclays Capital Securities Ltd 2,092,748株(0.71%)+0.1% |
| 07/29 | (IR情報)19:00 抗アミロイドβ抗体「レケンビ」の売上収益(速報)について |
| 07/29 | 4,861 | 5,110 | 4,846 | 5,110 | +6.66% | 3,429,200 | - | +17.44% |
| 07/28 | 4,766 | 4,816 | 4,750 | 4,791 | +0.8% | 1,836,300 | - | +11.37% |
| 07/27 | 4,649 | 4,786 | 4,636 | 4,753 | +2.08% | 2,045,100 | - | +11.39% |
| 07/27 | (空売り報告)Barclays Capital Securities Ltd 1,784,898株(0.61%)+0.04% |
| 07/24 | 4,597 | 4,678 | 4,563 | 4,656 | +1.62% | 1,441,600 | - | +9.99% |
| 07/23 | 4,550 | 4,585 | 4,515 | 4,582 | +0.7% | 1,202,400 | - | +8.97% |
| 07/22 | 4,450 | 4,607 | 4,440 | 4,550 | +1.52% | 1,564,000 | - | +8.98% |
| 07/21 | (5%ルール)アペリオ・グループ・エルエルシー(Aperio Group,…(0.12%)ブラックロック(ネザーランド)BV(BlackRock (Neth…(0.26%)ブラックロック(ルクセンブルグ)エス・エー(Black…(0.59%)ブラックロック・アセット・マネジメント・アイルラ…(1%)ブラックロック・アセット・マネジメント・カナダ・…(0.19%)ブラックロック・アドバイザーズ・エルエルシー(B…(0.18%)ブラックロック・インスティテューショナル・トラス…(1.2%)ブラックロック・インベストメント・マネジメント(…(0.76%)ブラックロック・ジャパン(1.92%)ブラックロック・ファンド・アドバイザーズ(Black…(1.9%)ブラックロック・ファンド・マネジャーズ・リミテッ…(0.25%)ブラックロック・フィナンシャル・マネジメント・イ…(0.12%) |
| 07/21 | 4,455 | 4,529 | 4,452 | 4,482 | +0.72% | 1,884,600 | - | +8.18% |
| 07/21 | (空売り報告)Barclays Capital Securities Ltd 1,667,998株(0.57%)-0.03% |
| 07/17 | 4,400 | 4,457 | 4,379 | 4,450 | +2.58% | 1,934,700 | - | +8.09% |
| 07/17 | (空売り報告)Barclays Capital Securities Ltd 1,755,998株(0.6%)+0.02% |
| 07/16 | 4,288 | 4,348 | 4,269 | 4,338 | +1.93% | 1,343,700 | - | +6.06% |
| 07/15 | 4,270 | 4,331 | 4,238 | 4,256 | -2.74% | 1,765,700 | - | +4.7% |
| 07/15 | (空売り報告)Barclays Capital Securities Ltd 1,705,398株(0.58%)-0.03% |
| 07/14 | 4,313 | 4,433 | 4,310 | 4,376 | +3.13% | 2,570,300 | - | +8.18% |
| 07/14 | (IR情報)8:30 抗Aβ抗体「レケンビ」の皮下注射製剤「LEQEMBI IQLIK」が早期アルツハイマー病に対する初期療法として米国FDAより承認取得 |
| 07/14 | (空売り報告)Barclays Capital Securities Ltd 1,782,798株(0.61%)+0.09% |
| 07/13 | 4,300 | 4,316 | 4,222 | 4,243 | -1.23% | 1,196,800 | - | +5.57% |
| 07/10 | 4,267 | 4,328 | 4,252 | 4,296 | +0.23% | 1,513,100 | - | +7.35% |
| 07/09 | 4,292 | 4,343 | 4,263 | 4,286 | -0.74% | 1,640,200 | - | +7.66% |
| 07/08 | 4,340 | 4,366 | 4,295 | 4,318 | +0.3% | 1,395,300 | - | +8.99% |
| 07/07 | 4,330 | 4,337 | 4,269 | 4,305 | -0.81% | 1,633,400 | - | +9.26% |
| 07/06 | (5%ルール)ノムラインターナショナルピーエルシー(NOMURA IN…(0%)野村アセットマネジメント(7.29%)野村證券(0.06%) |
| 07/06 | 4,305 | 4,352 | 4,280 | 4,340 | +2% | 1,289,000 | - | +10.71% |
| 07/03 | 4,301 | 4,342 | 4,242 | 4,255 | +1.6% | 1,598,200 | - | +9.13% |
| 07/02 | 4,175 | 4,188 | 4,114 | 4,188 | +1.92% | 1,778,100 | - | +7.72% |
| 07/01 | 4,065 | 4,129 | 4,050 | 4,109 | -0.24% | 1,072,700 | - | +5.98% |
| 06/30 | 4,167 | 4,170 | 4,110 | 4,119 | -0.63% | 1,818,900 | - | +6.32% |
| 06/30 | (空売り報告)JPM Securities Japan Co Ltd. 1,318,515株(0.45%)-0.12%義務消失 |
| 06/29 | 4,010 | 4,145 | 4,006 | 4,145 | +3.86% | 4,170,300 | - | +7.13% |
| 06/29 | (空売り報告)JPM Securities Japan Co Ltd. 1,673,211株(0.57%)再IN |
| 06/26 | 3,952 | 4,009 | 3,940 | 3,991 | +1.06% | 1,620,500 | - | +3.15% |
| 06/26 | (空売り報告)Barclays Capital Securities Ltd 1,541,312株(0.52%)再IN |
| 06/25 | 3,920 | 3,952 | 3,881 | 3,949 | +1.52% | 1,437,000 | - | +1.91% |
| 06/24 | 3,905 | 3,918 | 3,876 | 3,890 | -0.1% | 1,345,500 | - | +0.08% |
| 06/24 | (空売り報告)Barclays Capital Securities Ltd 1,125,812株(0.38%)-0.13%義務消失 |
| 06/23 | 3,903 | 3,947 | 3,894 | 3,894 | -0.18% | 1,736,100 | - | -0.18% |
| 06/22 | 3,861 | 3,908 | 3,822 | 3,901 | -0.03% | 1,395,000 | - | -0.59% |
| 06/19 | 3,900 | 3,944 | 3,872 | 3,902 | -1.69% | 2,438,200 | - | -1.09% |
| 06/19 | (空売り報告)Barclays Capital Securities Ltd 1,489,712株(0.51%)再IN |
| 06/18 | 3,888 | 3,976 | 3,881 | 3,969 | +3.66% | 2,448,700 | - | -0.23% |